Chiara Bazzichetto

Rome, 00144, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Interleukin-8: a tumor-agnostic biomarker integrating cancer biology and host response across solid tumors.

Interleukin-8: a tumor-agnostic biomarker integrating cancer biology and host response across solid tumors.

Journal: Cancer treatment reviews

Published: February 07, 2026

Interleukin-8 in health and disease.

Interleukin-8 in health and disease.

Journal: Molecular biomedicine

Published: September 09, 2025

HER2-Driven Breast Cancer: Role of the Chaperonin HSP90 in Modulating Response to Trastuzumab-Based Therapeutic Combinations.

HER2-Driven Breast Cancer: Role of the Chaperonin HSP90 in Modulating Response to Trastuzumab-Based Therapeutic Combinations.

Journal: International journal of molecular sciences

Published: May 23, 2025

Interleukin-8 as a potential prognostic biomarker in renal cell carcinoma: a systematic review and meta-analysis.

Interleukin-8 as a potential prognostic biomarker in renal cell carcinoma: a systematic review and meta-analysis.

Journal: The oncologist

Published: April 05, 2025

Induction of cell death by the CXCR2 antagonist SB225002 in colorectal cancer and stromal cells.

Induction of cell death by the CXCR2 antagonist SB225002 in colorectal cancer and stromal cells.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: February 14, 2025

Preserving momentum on next-generation sequencing for head and neck squamous cell carcinoma.

Preserving momentum on next-generation sequencing for head and neck squamous cell carcinoma.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: July 03, 2024

Prognostic impact of Interleukin-8 levels in lung cancer: A meta-analysis and a bioinformatic validation.

Prognostic impact of Interleukin-8 levels in lung cancer: A meta-analysis and a bioinformatic validation.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: May 23, 2024

Editorial: Tailoring immunotherapy in gastrointestinal cancer: the role of circulating factors.

Editorial: Tailoring immunotherapy in gastrointestinal cancer: the role of circulating factors.

Journal: Frontiers in oncology

Published: July 17, 2023

Bcl-2 family inhibitors sensitize human cancer models to therapy.

Bcl-2 family inhibitors sensitize human cancer models to therapy.

Journal: Cell death & disease

Published: January 18, 2023

Interleukin-8 in Colorectal Cancer: A Systematic Review and Meta-Analysis of Its Potential Role as a Prognostic Biomarker.

Interleukin-8 in Colorectal Cancer: A Systematic Review and Meta-Analysis of Its Potential Role as a Prognostic Biomarker.

Journal: Biomedicines

Published: September 15, 2022

Fibroblast-Induced Paradoxical PI3K Pathway Activation in PTEN-Competent Colorectal Cancer: Implications for Therapeutic PI3K/mTOR Inhibition.

Fibroblast-Induced Paradoxical PI3K Pathway Activation in PTEN-Competent Colorectal Cancer: Implications for Therapeutic PI3K/mTOR Inhibition.

Journal: Frontiers in oncology

Published: January 26, 2022

SEMA6A/RhoA/YAP axis mediates tumor-stroma interactions and prevents response to dual BRAF/MEK inhibition in BRAF-mutant melanoma.

SEMA6A/RhoA/YAP axis mediates tumor-stroma interactions and prevents response to dual BRAF/MEK inhibition in BRAF-mutant melanoma.

Journal: Journal of experimental & clinical cancer research : CR

Published: November 05, 2021

Showing 1-12 of 29

Last Updated: 09/26/2026